How to Cite
Abstract
Tumors of the oral cavity and pharynx make up the majority of so-called tumors of the head and neck and represent a heterogeneous group of tumors of different origin. Since 90% of these tumors are squamous cell carcinomas of the mucosa, literature often refers to this position. Except squamous cell carcinomas, different types of sarcomas, lymphomas, melanomas of the mucous membranes, benign tumors, etc. and pharynx may develop there.References
Имянитов Е.Н., Хансон К.П. Молекулярная онкология: клинические аспекты.- Спб: Издательский дом СПбМАПО. - 2007. - 211с.
Мерабишвили В.М. Выживаемость онкологических больных. Выпуск второй. - СПб.: Коста. -2011. -408 c.
Социально значимые заболевания населения России в 2008 году (Статистические материалы). Министерство здравоохранения и социального развития Российской Федерации. - М. - 2009 г.
Социально значимые заболевания населения России в 2009 году (Статистические материалы). Министерство здравоохранения и социального развития Российской Федерации. - М. - 2010 г.
Социально значимые заболевания населения России в 2010 году (Статистические материалы). Министерство здравоохранения и социального развития Российской Федерации. - М. - 2011 г.
Шилова О.Ю., Уразова Л.Н. Молекулярно-генетические методы прогноза и течения рака гортани // Сиб. онкол. журнал. - 2010. - №.5 - С. 64-70.
Abysheva S.N., Iyevleva A.G., Efimova N.V. et al. KIT mutations in Russian patients with mucosal melanoma // Melanoma Res. - 2011. - Vol.21. - P. 555-559.
Agrawal N., Frederick M.J. Pickering C.R. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 // Science. - 2011. - Vol. 333. - P. 1154-1157.
Barnes L., Eveson J.W., Reichart P., Sidransky D. (Eds): World Health Organization Classification of Tumours. Pathology and genetics of head and neck tumours, IARC Press: Lyon. - 2005.
Barrett A.W., Raja A.M. The immunohistochemical identification of human oral mucosal melanocytes // Arch oral Biol. - 1997. - Vol. 42. - P 77-81.
Boffetta P, Hecht S., Gray N. et al. Smokeless tobacco and cancer // Lancet oncol. - 2008. - Vol. 9. -P. 667-675.
Curado M.P, Boyle P. Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol // Curr opin oncol. - 2013. - Vol. - 25. - P. 229-234.
Epstein J.B., Epstein J.D., Le N.D. et al. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases // Oral Surg Oral Med Oral Pathol oral Radiol Endod. - 2001. - Vol. 92. - P. 519-525.
Ferlay J., Shin H.R., Bray F., Forman D., Mathers C. and Parkin D.M. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 26/08/2013
Fioretti F., Bosetti C., Tavani A. et al. Risk factors for oral and pharyngeal cancer in never smokers // Oral Oncol. - 1999. - Vol. 35. - P. 375-378.
Goldstein B.Y, Chang S.C., Hashibe M. et al. Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update // Eur J Cancer Prev. - 2010. - Vol. 19. - P. 431-465.
Hashibe M., Sturgis E.M. Epidemiology of oral-cavity and Oropharyngeal carcinomas: controlling a tobacco epidemic while a human papillomavirus epidemic emerges // Otolaryngol Clin North Am. - 2013. - Vol. 46. - P. 507-520.
Hicks M.J., Flaitz C.M. Oral mucosal melanoma: epidemiology and pathobiology // Oral Oncol. - 2000. - Vol. 36. - P. 152-169.
Hillbertz N.S., Hirsch J.M., Jalouli J. et al. Viral and molecular aspects of oral cancer // Anticancer Res. - 2012. - Vol. 32. - P. 4201-4212.
Hodi F.S., Friedlander P., Corless C.L. et al. Major response to imatinib mesylate in KIT-mutated melanoma // Journal of clinical oncology. - 2008. - Vol. 26. - P. 2046-2051.
Hodi F.S., Corless C.L., Giobbie-Hurder A. et al. Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin // J Clin Oncol.- 2013. - Vol. 31. -P. 3182-3190.
Huang X., Gollin S.M., Raja S. et al. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells // Proc Natl Acad Sci USA. - 2002. - Vol. 9. - P 11369-11374.
Johnson N. Tobacco use and oral cancer: a global perspective // J Dent Educ. - 2001. - Vol. 65. - P. 328339.
Mihajlovic M., Vlajkovic S., Jovanovic P. et al. Primary mucosal melanomas: a comprehensive review // Int J Clin Exp Pathol. - 2012. - Vol. 5. - P. 739-753.
Mota O.M., Curado M.P, Oliveira J.C. et al. Risk factors for esophageal cancer in a low-incidence area of Brazil // Sao Paulo Med J. - 2013. - Vol. 131. - P. 27-34.
Plonka P.M., Passeron T., Brenner M. et al. What are melanocytes really doing all day long..? // Exp Dermatol. - 2009. - Vol. 18. - P. 799-819.
Saman D.M. A review of the epidemiology of oral and pharyngeal carcinoma: update // Head Neck Oncol. - 2012. - Vol. 4. - P. 1.
Stransky N., Egloff A.M., Tward A.D. et al. The mutational landscape of head and neck squamous cell carcinoma // Science. - 2011. - Vol. 333. - P 1157-1160.
Tanaka N., Amagasa T., Iwaki H. et al. Oral malignant melanoma in Japan // Oral Surg Oral Med Oral Pathol. - 1994. - Vol. 78. - P. 81-90.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer // Oral Oncol. - 2009. - Vol. 45. - P. 309-316.
Zhai C., Li Y, Mascarenhas C. et al. The function of ORAOV1/LTO1, a gene that is overexpressed frequently in cancer: essential roles in the function and biogenesis of the ribosome // Oncogene. - 2013. Jan. 14. - P. 1-11
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2014